Exploring Intranasal Neomycin for Viral Immunity

This chapter examines a study on the potential of intranasal neomycin to stimulate antiviral immunity in the upper respiratory tract and its implications as a low-cost treatment for respiratory viruses. It discusses the challenges of dosage in human applications, the importance of timing in antiviral treatments, and concerns about antibiotic stewardship. The conversation highlights the need for further research to understand the effects of neomycin on the nasal microbiome and the ramifications for public health.